40
NPS Score
VS
Alnylam Pharmaceuticals
- EMPLOYEE
PARTICIPANTS - 23
- TOTAL
RATINGS
Intellia Therapeutics Claimed Company
- EMPLOYEE
PARTICIPANTS - 12
- TOTAL
RATINGS
Alnylam Pharmaceuticals vs Intellia Therapeutics
Compare Alnylam Pharmaceuticals versus Intellia Therapeutics for CEO Rating, Overall Culture Score, Brand Ranking, and other ratings. Results were generated by 23 employees and customers of Alnylam Pharmaceuticals and 12 employees and customers of Intellia Therapeutics.
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals's brand is ranked #- in the list of Global Top 1000 Brands, as rated by customers of Alnylam Pharmaceuticals. Their current market cap is $24.72B.
Intellia Therapeutics
Intellia Therapeutics's brand is ranked #- in the list of Global Top 1000 Brands, as rated by customers of Intellia Therapeutics. Their current market cap is $5.42B.
3.9/5
Product Quality
3.5/5
3.5/5
Pricing
3.3/5
3.4/5
Customer Service
3.9/5
| 70% | Promoters |
|---|---|
| 0% | Passive |
| 30% | Detractors |
49
NPS Score
| 66% | Promoters |
|---|---|
| 17% | Passive |
| 17% | Detractors |
Net Promoter Score
Winner by 9
See how Alnylam Pharmaceuticals compares to its competitors
See how Intellia Therapeutics compares to its competitors
Working at Alnylam Pharmaceuticals vs Working at Intellia Therapeutics
78 / 100
CEO Rating
86 / 100
CEO Rating
Winner by 8%
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals doesn't have enough ratings to calculate the Team Culture Ratings.
Know someone that works there? Invite them to rate their experience.
Intellia Therapeutics
Employees at Intellia Therapeutics rate their CEO, John Leonard, 86/100. This score is 8% higher than the scores of Alnylam Pharmaceuticals' CEO, John Maraganore.